Bioventus (BVS) Deferred Taxes (2020 - 2026)

Bioventus (BVS) has reported Deferred Taxes for 7 consecutive years, with -$22.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Deferred Taxes fell 50756.82% year-over-year to -$22.3 million; the trailing twelve-month figure through Jun 2026 stood at -$23.2 million (down 929.45% YoY), and the FY2025 full-year result was -$909000.0, up 83.15% from the prior year.
• Deferred Taxes declined to -$22.3 million in Q2 2026 per BVS's latest filing, from $135000.0 in the prior quarter.
• Across five years, Deferred Taxes topped out at $3.2 million in Q4 2024 and bottomed at -$22.3 million in Q2 2026.
• Historically, Deferred Taxes has averaged -$4.6 million across 5 years, with a median of -$876000.0 in 2023.
• The widest YoY moves for Deferred Taxes: up 213.95% in 2026, down 50756.82% in 2026.
• Over 5 years, Deferred Taxes stood at -$11.8 million in 2022, then soared by 109.88% to $1.2 million in 2023, then surged by 176.44% to $3.2 million in 2024, then sank by 135.18% to -$1.1 million in 2025, then sank by 1870.73% to -$22.3 million in 2026.
• According to Business Quant data, Deferred Taxes over the past three periods registered -$22.3 million, $135000.0, and -$1.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.